Lyonnet S
Clinique et Unité de recherches de Génétique médicale, INSERM U-12, hôpital des Enfants-Malades, Paris, France.
Pediatrie. 1987;42(6):425-35.
In this short survey, the author analyzes the main principles and some of the methods used for the analysis, at the molecular level, of a mutation causing a monogenic disease. The recent advances in molecular biology techniques allow the identification of such a molecular lesion in the human genome. A molecular probe, i.e. an isolated fragment of DNA, is the main tool for such a purpose; it is necessary for recognizing, isolating and analyzing an abnormal gene. When no molecular probe is available or when the primary defect responsible for the disease is unknown (Duchenne muscular dystrophy, cystic fibrosis), the strategy of "reverse genetics" briefly exposed here is a breakthrough in the molecular genetics of hereditary diseases.
在这项简短的综述中,作者分析了在分子水平上对导致单基因疾病的突变进行分析所使用的主要原理和一些方法。分子生物学技术的最新进展使得在人类基因组中识别这种分子损伤成为可能。分子探针,即分离的DNA片段,是实现这一目的的主要工具;它对于识别、分离和分析异常基因是必要的。当没有可用的分子探针,或者当导致疾病的主要缺陷未知时(如杜氏肌营养不良症、囊性纤维化),这里简要介绍的“反向遗传学”策略是遗传性疾病分子遗传学领域的一项突破。